VEGF release is associated with reduced oxygen tensions in experimental inflammatory arthritis

Clinical and Experimental Rheumatology

Volumn 20, Issue 6, 2002, Pages 799-805

  Etherington, P J ^a   Winlove, P ^b   Taylor, P ^a   Paleolog, E ^a   Miotla, Jadwiga M ^a,c  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Collagen induced arthritis; Rheumatoid arthritis; Vascular endothelial growth factor

Indexed keywords

COLLAGEN TYPE 2; MESSENGER RNA; VASCULOTROPIN; CD31 ANTIGEN; ENDOTHELIAL CELL GROWTH FACTOR; FREUND ADJUVANT; LYMPHOKINE; OXYGEN; SIGNAL PEPTIDE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; HOMEOSTASIS; JOINT CAVITY; KNEE; MALE; MICROELECTRODE; MOUSE; NONHUMAN; OXYGEN TENSION; OXYGENATION; PERFUSION; POLAROGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; ANIMAL; ARTHRITIS; GENETICS; IMAGE PROCESSING; IMMUNOLOGY; JOINT; METABOLISM; OXYGEN CONSUMPTION; PATHOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD31; ARTHRITIS, EXPERIMENTAL; COLLAGEN TYPE II; ENDOTHELIAL GROWTH FACTORS; FREUND'S ADJUVANT; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JOINTS; LYMPHOKINES; MALE; MICE; MICROELECTRODES; OXYGEN; OXYGEN CONSUMPTION; POLAROGRAPHY; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036900853     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. PALEOLOG EM, MIOTLA JM: Angiogenesis in arthritis: Role in disease pathogenesis and as a potential theraeutic target. Angiogenesis 1998; 2: 295-307.
2. BALLARA SC, MIOTLA JM, PALEOLOG EM: New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders. Int Journal Exp Pathol 1999; 80: 235-50.
3. LUND-OLESEN K: Oxygen tension in synovial fluids. Arthritis Rheum 1970; 13: 769-76.
4. BLAKE DR, MERRY P, UNSWORTH J et al.: Hypoxic-reperfusion injury in the inflamed human joint. Lancet 1989;1 (8633):289-293.
5. STEVENS CR, WILLIAMS RB, FARRELL AJ, BLAKE DR: Hypoxia and inflammatory synovitis: observations and speculation. Ann Rheum Dis 1991; 50: 124-32.
6. FOLKMAN J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1995; 1: 27-31.
7. CEPONIS A, KONTTINEN YT, IMAI S et al.: Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: a comparative quantitative morphometric study. Br J Rheumatol 1998; 37: 170-8.
8. WALSH DA, WADE M, MAPP PI, BLAKE DR: Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol 1998; 152: 691-702.
9. BROWN LF, DETMAR M, CLAFFEY K et al.: Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine. EXS 1997; 79: 233-69.
10. ACHEN MG, STACKER SA: The vascular endothelial growth factor family; proteins which guide the development of the vasculature. Int J Exp Pathol 1998; 79: 255-65.
11. NEUFELD G, COHEN T, GENGRINOVITCH S, POLTORAK Z: Vascular endothelial growth factor (VEGF) and its receptors. Faseb J 1999; 13: 9-22.
12. FAVA RA, OLSEN NJ, SPENCER-GREEN G et al.: Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994; 180: 341-6.
13. KOCH AE, HARLOW LA, HAINES GK et al.: Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994; 152: 4149-56.
14. NAGASHIMA M, YOSHINO S, ISHIWATA T, ASANO G: Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 1995; 22: 1624-30.
15. SHWEIKI D, ITIN A, SOFFER D, KESHET E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-5.
16. LU J, KASAMA T, KOBAYASHI K et al.: Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J Immunol 2000; 164: 5922-7.
17. MIOTLA J, MACIEWICZ R, KENDREW J, FELDMANN M, PALEOLOG E: Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest 2000; 80:1195-1205.
18. MILLER EJ: Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin. Biochemistry 1972; 11: 4903-9.
19. BUTLER DM, MALFAIT AM, MASON LJ et al.: DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. J Immunol 1997; 159: 2867-76.
20. MALFAIT AM, BUTLER DM, PRESKY DH, MAINI RN, BRENNAN FM, FELDMANN M: Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis. Clin Exp Immunol 1998; 111: 377-83.
21. O'HARE D, WINLOVE CP, PARKER KH: Electrochemical method for direct measurement of oxygen concentration and diffusivity in the intervertebral disc: electrochemical characterization and tissue-sensor interactions. J Biomed Eng 1991; 13: 304-12.
22. 2 analysis in blood and gas. J Appl Physiol 1978; 45: 637-43.
23. SAIR M, ETHERINGTON PJ, CURZEN NP, WINLOVE CP, EVANS TW: Tissue oxygenation and perfusion in endotoxemia. Am J Physiol 1996; 271: H1620-1625.
24. BARRON DJ, ETHERINGTON PJ, WINLOVE CP, JARVIS JC, SALMONS S, PEPPER JR: Muscle transformation in cardiomyoplasty: the effect of conditioning and mobilisation on perfusion, oxygenation and fatigue resistance in the latissimus dorsi muscle. Eur J Cardiothorac Surg 1998; 13: 588-98.
25. Al-OBAIDI MK, ETHERINGTON PJ, BARRON DJ, WINLOVE CP, PEPPER JR: Myocardial tissue oxygen supply and utilization during coronary artery bypass surgery: evidence of microvascular no-reflow. Clin Sci (Colch) 2000; 98: 321-8.
26. ULFGREN AK, ANDERSSON U, ENGSTROM M, KLARESKOG L, MATNI RN, TAYLOR PC: Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis. Arthritis Rheum 2000; 43: 2391-6.
27. BERSE B, HUNT J, DIEGEL R et al.: Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 1999; 115:176-82.
28. PALEOLOG EM, YOUNG S, STARK AC, McCLOSKEY RV, FELDMANN M, MAINI RN: Modulation of angiogenic vascular endothelial growth factor (VEGF) by TNFα and IL-1 in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1258-65.
29. BARLEON B, SOZZANI S, ZHOU D, WEICH HA, MANTOVANI A, MARME D: Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 Blood 1996; 87: 3336-43.
30. KASAMA T, KOBAYASHI K, YAJIMA N, et al.: Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA). Clin Exp Immunol 2000; 121: 533-8.
31. ELLIOTT MJ, MAINI RN, FELDMANN M et al.: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344: 1105-10.
32. MAINI RN, TAYLOR PC: Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med 2000; 51: 207-29.
33. ANDERSSON SE, EKSTROM GM: Changes in vascular porosity and joint blood flow during development of collagen induced arthritis in the rat. Modulation by indomethacin and L-NAME. J Rheumatol 1997; 24: 2188-95.
34. STENDER HANSEN E, HE SZ, HJORTDAL VE, KJOLSETH D, SOBALLE K: Distribution of blood flow in normal and arthritic joints Role of ateriovenous shunting studied in growing dogs. Am J Physiol 1992; 262:H38-46.